No Data
No Data
Adastria Announces Strategic Company Split to Enhance E-commerce Platform
Adastria Co. Integrates ADOORLINK to Boost Sustainability
Adastria to Merge With TODAY'S SPECIAL for Growth
PolAOL HD, DaiKin ETC (additional) Rating
Upgraded - Bullish Code Stock Name Securities Company Previous Change After---------------------------------------------------<6135> Makino F SMBC Nikko "2" "1" <8750> Dai-ichi Life Holdings Mizuho "Hold" "Buy" <8795> T&D Holdings Mizuho "Hold" "Buy" Downgraded - Bearish Code Stock Name Securities Company Previous Change After-----------------------------------------
December 4th [Today's Investment Strategy]
[FISCO Selected Stocks] [Material Stocks] JCR Pharma <4552> 727 yen (12/3) Human growth hormone preparations are the main products. Regarding the blood-brain barrier crossing type α-N-acetylglucosaminidase preparation (JR-446) developed by the company, the first administration to the first subject targeted at mucopolysaccharidosis type 3B (MPS3B) in clinical phase 1/2 trials in Japan was announced. MPS3B is being jointly developed and commercialized with Medipal Holdings <7459>.
Pay attention to JCR Pharma and ABC Mart, while Uchida Yoko and Tsukishima HD may be sluggish.
In the U.S. stock market on the 3rd of yesterday, the dow jones industrial average decreased by 76.47 dollars, closing at 44,705.53, the nasdaq rose by 76.96 points to 19,480.91, and the Chicago Nikkei 225 futures increased by 90 yen compared to during the day in Osaka, reaching 39,240 yen. The exchange rate is 1 dollar = 149.50-150.00 yen. In today's Tokyo market, the same-store sales for November increased by 14.7%, expanding from the 6.3% growth in October for ABC Mart <2670>, and the same-store sales for November rose by 8.9%, compared to the 6.3% in October.
No Data